Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing
Authors:
- Pei Sze NgPNPei Sze Ng
- Wei Xiong WenWWWei Xiong Wen
- Muhammad Zaki Hidayatullah FadlullahMFMuhammad Zaki Hidayatullah Fadlullah
- Sook‐Yee YoonSYSook‐Yee Yoon
- Sheau Yee LeeSLSheau Yee Lee
- Meow‐Keong ThongMTMeow‐Keong Thong
- Cheng Har YipCYCheng Har Yip
- Nur Aishah Mohd TaibNTNur Aishah Mohd Taib
- Soo‐Hwang TeoSTSoo‐Hwang Teo
- 3 February 2016
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 90 (4) , 315-323
Abstract
Although an association between protein‐truncating variants and breast cancer risk has been established for 11 genes, only alterations in BRCA1, BRCA2, TP53 and PALB2 have been reported in Asian populations. Given that the age of onset of breast cancer is lower in Asians, it is estimated that inherited predisposition to breast cancer may be more significant. To determine the potential utility of panel testing, we investigated the prevalence of germline alterations in 11 established and 4 likely breast cancer genes in a cross‐sectional hospital‐based cohort of 108 moderate to high‐risk breast cancer patients using targeted next generation sequencing. Twenty patients (19%) were identified to carry deleterious mutations, of whom 13 (12%) were in the BRCA1 or BRCA2, 6 (6%) were in five other known breast cancer predisposition genes and 1 patient had a mutation in both BRCA2 and BARD1. Our study shows that BRCA1 and BRCA2 account for the majority of genetic predisposition to breast cancer in our cohort of Asian women. Although mutations in other known breast cancer genes are found, the functional significance and breast cancer risk have not yet been determined, thus limiting the clinical utility of panel testing in Asian populations.Keywords
Funding Information
- Malaysian Ministry of Science, Technology and Innovation (10-06-06-MEB005)
- Malaysian Ministry of Higher Education (University Malaya HIR Grant) (UM.C/HIR/MOHE/06)
- Cancer Research Initiatives Foundation
This publication has 26 references indexed in Scilit:
- Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countriesJournal of Medical Genetics, 2015
- Gene-Panel Sequencing and the Prediction of Breast-Cancer RiskNew England Journal of Medicine, 2015
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast CancerJournal of Clinical Oncology, 2015
- Inherited predisposition to breast cancer among African American womenBreast Cancer Research and Treatment, 2014
- Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and PreventionScience, 2014
- Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and SingaporePLOS ONE, 2013
- Hereditary Breast Cancer in the Han Chinese PopulationJournal of Epidemiology, 2013
- Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patientsBreast Cancer Research, 2012
- Prevalence of TP53 germ line mutations in young Pakistani breast cancer patientsFamilial Cancer, 2012
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences, 2010